Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
TN1458 |
Buddlejasaponin IV
|
PARP; Akt; Chk | Cell Cycle/Checkpoint; Chromatin/Epigenetic; Cytoskeletal Signaling; DNA Damage/DNA Repair; PI3K/Akt/mTOR signaling |
Buddlejasaponin IV has analgesic and anti-inflammatory effects, the inhibitions of the expressions of iNOS, COX-2, TNF-alpha, IL-1beta and IL-6 by blocking NF-kappaB activation. |